DuPont de Nemours vs Rogers
DD and ROG side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DD and ROG compare
DuPont de Nemours is the larger company, worth 9.1 times as much as Rogers ($21.2B against $2.3B).
On earnings, Rogers is cheaper: it trades at 51.7× trailing earnings, against 349× for DuPont de Nemours.
Rogers grew revenue faster over the last twelve months (6.7% versus 3.3% for DuPont de Nemours).
Rogers keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with 0.79% at DuPont de Nemours.
DuPont de Nemours pays a dividend yielding 1.5%; Rogers does not pay one.
Rogers scores higher on the StockData Score (11 against 8 for DuPont de Nemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DD | ROG |
|---|---|---|
| Size and price | ||
| Market cap | $21.2B | $2.3B |
| Share price | $156.88 | $130.89 |
| Change, 1 year | 31.4% | 53.9% |
| Change, 5 years | −34.6% | −51.5% |
| Beta (5Y) | 1.14 | 0.86 |
| Employees | 15K | 3,000 |
| StockData Score | ||
| Total score | 8 | 11 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 0 | 2 (better) |
| Health score | 4 | 6 (better) |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 349× | 51.7× (better) |
| P/S | 3.0× | 2.7× (better) |
| P/B | 1.5× (better) | 1.9× |
| EV/EBITDA | 24.8× | 17.1× (better) |
| P/FCF | 30.2× | 24.0× (better) |
| FCF yield | 3.3% | 4.2% (better) |
| Fair value | $98.38 | $96.27 |
| Margin of safety | −59.5% | −36.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 3.3% | 6.7% (better) |
| Revenue growth, 5Y average | −9.3% | 0.20% (better) |
| Profitability | ||
| Gross margin | 35.1% (better) | 32.7% |
| Operating margin | – | 7.9% |
| Net margin | 0.79% | 5.3% (better) |
| FCF margin | 10.0% | 11.3% (better) |
| Return on equity | 0.30% | 3.7% (better) |
| Return on invested capital | – | 4.2% |
| Financial health | ||
| Debt / equity | 0.23 (better) | 0.00 |
| Net debt / EBITDA | 1.52 | – |
| Current ratio | 2.43 | 4.14 (better) |
| Altman Z-score | 0.65 | 8.09 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.5% | – |
| Payout ratio | 758% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 3.6% | – |
| Buyback yield | −0.64% | – |
| Shareholder yield | 0.89% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 73.7% | 103% |
| Held by insiders | 0.75% | 4.6% |
| Insider net buying, 12 months | −$14.2M | −$1.6M (better) |
| Short interest, % of float | 2.9% | 2.5% |
Go deeper
- DD stock overview
- DD income statement
- DD valuation and score
- ROG stock overview
- ROG income statement
- ROG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.